Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial.

ABSTRACT:

SUBMITTER: Sharman JP 

PROVIDER: S-EPMC8151619 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature